Jefferies Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $7.49M | Buy |
105,300
+10,000
| +10% | +$725K | 0.06% | 255 |
|
|
2022
Q2 | $7.34M | Buy |
95,300
+35,300
| +59% | +$2.69M | 0.06% | 262 |
|
|
2022
Q1 | $4.38M | Sell |
60,000
-90,000
| -60% | -$6.04M | 0.03% | 451 |
|
|
2021
Q4 | $9.35M | Buy |
150,000
+110,000
| +275% | +$6.45M | 0.05% | 286 |
|
|
2021
Q3 | $2.37M | Buy |
+40,000
| New | +$2.63M | 0.02% | 705 |
|
|
2021
Q2 | – | Sell |
-30,000
| Closed | -$1.89M | – | 1683 |
|
|
2021
Q1 | $1.89M | Buy |
30,000
+12,400
| +70% | +$771K | 0.02% | 705 |
|
|
2020
Q4 | $1.09M | Hold |
17,600
| – | – | 0.01% | 917 |
|
|
2020
Q3 | $1.06M | Sell |
17,600
-1,600
| -8% | -$96.3K | 0.01% | 780 |
|
|
2020
Q2 | $1.13K | Sell |
19,200
-26,200
| -58% | -$1.57M | 0.01% | 721 |
|
|
2020
Q1 | $2.53M | Sell |
45,400
-748,100
| -94% | -$45.7M | 0.03% | 573 |
|
|
2019
Q4 | $50.9M | Buy |
793,500
+533,200
| +205% | +$30.5M | 0.39% | 35 |
|
|
2019
Q3 | $13.2M | Sell |
260,300
-749,200
| -74% | -$35.2M | 0.1% | 144 |
|
|
2019
Q2 | $45.8M | Sell |
1,009,500
-2,295,800
| -69% | -$107M | 0.33% | 30 |
|
|
2019
Q1 | $158M | Buy |
3,305,300
+3,189,200
| +2,747% | +$159M | 1.3% | 11 |
|
|
2018
Q4 | $6.04M | Sell |
116,100
-9,500
| -8% | -$510K | 0.05% | 348 |
|
|
2018
Q3 | $7.8M | Buy |
125,600
+24,700
| +24% | +$1.47M | 0.05% | 349 |
|
|
2018
Q2 | $5.58M | Sell |
100,900
-107,900
| -52% | -$5.83M | 0.03% | 475 |
|
|
2018
Q1 | $13.2M | Sell |
208,800
-36,500
| -15% | -$2.35M | 0.07% | 187 |
|
|
2017
Q4 | $15M | Buy |
245,300
+79,200
| +48% | +$4.95M | 0.07% | 199 |
|
|
2017
Q3 | $10.6M | Sell |
166,100
-54,900
| -25% | -$3.21M | 0.07% | 260 |
|
|
2017
Q2 | $12.3M | Sell |
221,000
-112,400
| -34% | -$6.12M | 0.08% | 226 |
|
|
2017
Q1 | $18.1M | Sell |
333,400
-938,200
| -74% | -$51.5M | 0.13% | 125 |
|
|
2016
Q4 | $74.3M | Buy |
1,271,600
+772,600
| +155% | +$42.2M | 0.42% | 30 |
|
|
2016
Q3 | $26.9M | Buy |
499,000
+420,700
| +537% | +$27M | 0.14% | 117 |
|
|
2016
Q2 | $5.76M | Sell |
78,300
-1,800
| -2% | -$127K | 0.03% | 455 |
|
|
2016
Q1 | $5.12M | Sell |
80,100
-23,000
| -22% | -$1.45M | 0.03% | 478 |
|
|
2015
Q4 | $7.09M | Buy |
103,100
+89,600
| +664% | +$5.92M | 0.04% | 349 |
|
|
2015
Q3 | $799K | Buy |
13,500
+6,600
| +96% | +$419K | ﹤0.01% | 1305 |
|
|
2015
Q2 | $459K | Sell |
6,900
-88,500
| -93% | -$5.83M | ﹤0.01% | 1601 |
|
|
2015
Q1 | $6.15M | Sell |
95,400
-266,900
| -74% | -$16.7M | 0.03% | 362 |
|
|
2014
Q4 | $21.4M | Buy |
362,300
+62,300
| +21% | +$3.51M | 0.13% | 137 |
|
|
2014
Q3 | $15.4M | Buy |
+300,000
| New | +$15M | 0.11% | 172 |
|
|
2014
Q2 | – | Sell |
-304,400
| Closed | -$15.8M | – | 2080 |
|
|
2014
Q1 | $15.8M | Buy |
+304,400
| New | +$16.2M | 0.15% | 123 |
|
Other funds holding BMY
Jefferies Group's BMY Position: Q3 2022 in Review
Jefferies Group sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 44,000 shares — an estimated $3.19M sold.
Jefferies Group first reported a position in BMY in Q2 2013 and held it in 37 quarters. The position peaked at $28.4M in Q4 2016. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Jefferies Group reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
- Jefferies Group sold 44,000 Bristol-Myers Squibb shares in Q3 2022, an estimated $3.19M.
- Jefferies Group first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 37 quarters.
- Jefferies Group's Bristol-Myers Squibb position peaked at $28.4M in Q4 2016.
- 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.